「place」の検索結果
39件：6～10件目を表示
-
ce successful completion of Phase III clinical trials in Japan, which consisted of the comparative (placebo-controlled) trial and the long-term administration trial. During the comparative trial, the ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
Publications | Research & Development | SENJU Pharmaceutica
開発本部 メディカルアフェアーズ部 ＊2 ケイシン五反田アイクリニック 医学と薬学, 83(1) 1-11, 2026 Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disea...
http://www.senju.co.jp/english/rd/thesis/ -
学会发表 | 研究与开发 | 千寿制药株式会社
Kong Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Minoru Kanamoto...
http://www.senju.co.jp/chinese/rd/society/ -
发表论文 | 研究与开发 | 千寿制药株式会社
開発本部 メディカルアフェアーズ部 ＊2 ケイシン五反田アイクリニック 医学と薬学, 83(1) 1-11, 2026 Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disea...
http://www.senju.co.jp/chinese/rd/thesis/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
Kong Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Minoru Kanamoto...
https://www.senju.co.jp/english/rd/society/